yttrium radioisotopes has been researched along with Hepato-Pulmonary Syndrome in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amour, ES; Gandhi, RT; Harnain, C; Schiro, BJ | 1 |
| Bui, JT; Casadaban, LC; Dikopf, MS; Gaba, RC; Lu, Y; Parvinian, A; Zivin, SP | 1 |
| Kadoch, MA; Kao, PN; Lam, MG; Louie, JD; Shah, RP; Sze, DY; Tamrazi, A; Ward, TJ | 1 |
| Gaba, RC; Vanmiddlesworth, KA | 1 |
4 other study(ies) available for yttrium radioisotopes and Hepato-Pulmonary Syndrome
| Article | Year |
|---|---|
Management of High Hepatopulmonary Shunts in the Setting of Y90 Radioembolization.
Topics: Embolization, Therapeutic; Hepatopulmonary Syndrome; Humans; Liver Neoplasms; Microspheres; Patient Care Planning; Patient Selection; Radiation Injuries; Radiotherapy Dosage; Yttrium Radioisotopes | 2019 |
Characteristics of primary and secondary hepatic malignancies associated with hepatopulmonary shunting.
Topics: Adult; Aged; Aged, 80 and over; Angiography; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Gamma Cameras; Hepatopulmonary Syndrome; Humans; Liver Neoplasms; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Technetium Tc 99m Aggregated Albumin; Treatment Outcome; Yttrium Radioisotopes | 2014 |
Management of High Hepatopulmonary Shunting in Patients Undergoing Hepatic Radioembolization.
Topics: California; Comorbidity; Extravasation of Diagnostic and Therapeutic Materials; Female; Hepatopulmonary Syndrome; Humans; Incidence; Liver Neoplasms; Male; Middle Aged; Radiation Injuries; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Treatment Outcome; Yttrium Radioisotopes | 2015 |
Chemoembolic hepatopulmonary shunt reduction to allow safe yttrium-90 radioembolization lobectomy of hepatocellular carcinoma.
Topics: Aged; Angiography; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Contrast Media; Hepatopulmonary Syndrome; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Portal Vein; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Aggregated Albumin; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2012 |